Global Cholera Vaccines Market to Grow Significantly at a Rapid Pace of 9.56% during 2018-2022

Published on : Jan 12, 2018

Albany, New York, January 12, 2018: Presently, over 600 million people throughout the globe are at risk of contracting cholera. It causes diarrhea and severe dehydration. If untreated, it can be fatal. Today, the presence of wide range of promising vaccine candidates in the pipeline is anticipated to accentuate growth of the cholera vaccines market in the coming years. Market Research Hub (MRH) has freshly broadcasted a new study to its vast repository, which is titled as “Global Cholera Vaccines Market 2018-2022” and offers a holistic perspective on the current market scenario. It further delivers insightful forecast on how the demand for cholera vaccines will expand in the near future.

Cholera Vaccine plays an important role in outbreak prevention and control, and in long-term control of cholera. In the present time, the cholera vaccines market appears to be concentrated due to the presence of few established players. The presence of a rich pipeline, strategic partnerships, and operational base are the other major competitive factors among cholera vaccine manufacturers. As per the report key findings, the global cholera vaccines market predicted to grow at a CAGR of 9.56% during the period 2018-2022.

It has been also stated in the study that a major percentage of the world’s population is lacking basic sanitization facilities such as soaps to wash hands. These are prominent in countries where the income of the major population is low and medium. This increases the need for cholera vaccines in these countries, providing significant growth opportunities for cholera vaccine manufacturers.

Report Inclusion

This 103-page study provides a detailed insight into key drivers and restraints, notable trends, share and size of various segments, and competitive landscape for the market of cholera vaccines. For the benefit of the readers, the report provides a complete perspective on the market’s size on the basis of revenue generated from the sales of cholera vaccines, covering different geographical regions namely the Asia Pacific, Americas, Europe, Middle East & Africa. Key industry developments include the major events that took place in the past decade and the events that are expected to take place in the future which is anticipated to affect the market are also defined in the report.

Moreover, the market has been analyzed on the basis of product type, which Shancol, DUKORAL and Vaxchora. Of these, Shanchol segment accounted for the major share of the cholera vaccines market since this vaccine provides better long-term protection for children especially under the age of six. Countries such as Congo, Yemen, South Sudan, Mozambique, and Haiti and these countries are the major adopters of Shanchol. From a geographical standpoint, EMEA will be the major revenue contributor to the cholera vaccines market throughout the forecast period.

Another vital section of the report is competitive landscape featuring some of the top companies, their products and business strategies, and their standing in the global market. At present, key players in the global cholera vaccines market include Sanofi, Valneva, and PaxVax.

Request a Sample with TOC in a PDF format :

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email :

Back To Top